Biomarin Pharmaceutical (NASDAQ:BMRN): Q2 EPS of -$0.16 beats by $0.14. Revenue of $136.8M (+10.3% Y/Y) beats by $2.47M. Shares -1% AH. (PR)
Biomarin Pharmaceutical (NASDAQ:BMRN): Q2 EPS of -$0.16 beats by $0.14. Revenue of $136.8M...
Recommended For You
More Trending News
About BMRN Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
BMRN | - | - |
BioMarin Pharmaceutical Inc. |